ATE392408T1 - Cyclopentenon-derivate für krebs-therapie - Google Patents

Cyclopentenon-derivate für krebs-therapie

Info

Publication number
ATE392408T1
ATE392408T1 AT02808276T AT02808276T ATE392408T1 AT E392408 T1 ATE392408 T1 AT E392408T1 AT 02808276 T AT02808276 T AT 02808276T AT 02808276 T AT02808276 T AT 02808276T AT E392408 T1 ATE392408 T1 AT E392408T1
Authority
AT
Austria
Prior art keywords
cancer therapy
cyclopentenone
derivatives
cyclopentenone derivatives
inhibition
Prior art date
Application number
AT02808276T
Other languages
English (en)
Inventor
M Gurjar
R Wakharkar
H B R Borate
Gautam Desiraju
Ashwini Nangia
Sanjay Sarkhel
K V V M Sairam
J S Yadav
S Chandrasekhar
Anand Burman
Rama Mukherjee
Manu Jaggi
Anu Singh
Kamal Kapoor
Original Assignee
Dabur Res Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Res Foundation filed Critical Dabur Res Foundation
Application granted granted Critical
Publication of ATE392408T1 publication Critical patent/ATE392408T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/34Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32Oximes
    • C07C251/62Oximes having oxygen atoms of oxyimino groups esterified
    • C07C251/64Oximes having oxygen atoms of oxyimino groups esterified by carboxylic acids
    • C07C251/66Oximes having oxygen atoms of oxyimino groups esterified by carboxylic acids with the esterifying carboxyl groups bound to hydrogen atoms, to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/90Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/013Esters of alcohols having the esterified hydroxy group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02808276T 2002-12-20 2002-12-20 Cyclopentenon-derivate für krebs-therapie ATE392408T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2002/000239 WO2004056738A1 (en) 2002-12-20 2002-12-20 Cyclopentenone derivatives for cancer therapy

Publications (1)

Publication Number Publication Date
ATE392408T1 true ATE392408T1 (de) 2008-05-15

Family

ID=32676745

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02808276T ATE392408T1 (de) 2002-12-20 2002-12-20 Cyclopentenon-derivate für krebs-therapie

Country Status (6)

Country Link
EP (1) EP1581471B9 (de)
AT (1) ATE392408T1 (de)
AU (1) AU2002356434A1 (de)
CA (1) CA2511219C (de)
DE (1) DE60226181T2 (de)
WO (1) WO2004056738A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013003729A1 (en) 2011-06-29 2013-01-03 The Penn State Research Foundation Compositions, methods and kits for treating leukemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664272B2 (en) * 1999-12-03 2003-12-16 Emory University Curcumin analogs with anti-tumor and anti-angiogenic properties
WO2001081288A1 (en) * 2000-04-27 2001-11-01 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University Hydroxyphenstatin and the prodrugs thereof

Also Published As

Publication number Publication date
CA2511219C (en) 2010-08-24
AU2002356434A1 (en) 2004-07-14
EP1581471A1 (de) 2005-10-05
CA2511219A1 (en) 2004-07-08
DE60226181T2 (de) 2009-05-07
WO2004056738A1 (en) 2004-07-08
EP1581471B9 (de) 2008-08-13
DE60226181D1 (de) 2008-05-29
EP1581471B1 (de) 2008-04-16

Similar Documents

Publication Publication Date Title
ATE408601T1 (de) Fredericamycin-derivate
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
MY140031A (en) Carbonyl compounds
NZ506329A (en) Inhibitors of phospholipase enzymes
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
MXPA04004347A (es) Nuevos fotoindicadores difuncionales.
MXPA04006255A (es) Compuestos novedosos de alquil/aril hidroxi o ceto tiepina como inhibidores del transporte del acido biliar codependiente del sodio apical y la captacion de taurocolato.
DE69940320D1 (de) Betulinsäurederivate zur inhibierung des krebswach
MXPA06014535A (es) Indoles utiles en el tratamiento de la inflamacion.
IT1315267B1 (it) Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
NO20055612L (no) Anti-inflammatoriske fosfonatforbindelser
ATE443044T1 (de) Tace inhibitoren
MY141233A (en) Enantiomers of selected fused heterocyclics and uses thereof
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
DE602004018811D1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
PL1831209T3 (pl) Inhibitory fosfataz cdc25
SE0002739D0 (sv) New use
ATE392408T1 (de) Cyclopentenon-derivate für krebs-therapie
CY1111289T1 (el) Συνθεσεις αναστολεων ογκου που περιεχουν νιτροακριδινη
ATE435224T1 (de) Neue piperidinsubstituierte diaminothiazole
MX2007001954A (es) Heterociclicos fusionados seleccionados y sus usos.
ATE276259T1 (de) Dihydroporphyrinderivate und ihre verwendung
ATE432933T1 (de) Flavopereirinderivate zur krebstherapie
AU2003236701A1 (en) Guanidino phenylalanin compounds used as urokinase inhibitors
DK1814879T3 (da) Derivater af 4,7-dioxobenzothiazol-2-caboxamider, fremgangsmåde til fremstilling deraf og terapeutiske anvendelser af samme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties